Advertisement
Fulllength article| Volume 216, P69-73, September 2017

Download started.

Ok

Diminished ovarian reserve in women with transfusion-dependent beta-thalassemia major: Is iron gonadotoxic?

      Abstract

      Objective

      Iron accumulation in the endocrine glands has been implicated in the aetiopathogenesis of decreased reproductive capacity in patients with beta-thalassemia major (β-TM). The aim of the current study was to investigate the serum concentration of anti-Müllerian hormone (AMH), a marker of ovarian reserve, in women with transfusion-dependent β-TM.

      Study design

      In this case-control study, we recruited 43 women with transfusion-dependent TM and 44 age-matched healthy controls. Hormonal and haematological parameters, serum level of AMH, antral follicle count, and ovarian volume were assessed.

      Results

      Twenty-two of the 43 women were hypogonadotropic, 8 with primary amenorrhea and 14 with secondary amenorrhea. FSH, LH, estradiol, prolactin, and AMH levels; antral follicle count; and ovarian volume were significantly lower in women with TM compared with the control group (p < 0.05 for all).

      Conclusion

      AMH level and other ovarian reserve markers are significantly diminished in women with transfusion-dependent TM compared to age-matched controls. Our findings support a deleterious effect of iron overload on ovarian tissue.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Noetzli L.J.
        • Panigrahy A.
        • Mittelman S.D.
        • Hyderi A.
        • Dongelyan A.
        • Coates T.D.
        • et al.
        Pituitary iron and volume predict hypogonadism in transfusional iron overload.
        Am J Hematol. 2012; 87: 167-171
        • Noetzli L.J.
        • Mittelman S.D.
        • Watanabe R.M.
        • Coates T.D.
        • Wood J.C.
        Pancreatic iron and glucose dysregulation in thalassemia major.
        Am J Hematol. 2012; 87: 155-160
        • Borgna-Pignatti C.
        • Rugolotto S.
        • De Stefano P.
        • Zhao H.
        • Cappellini M.D.
        • Del Vecchio G.C.
        • et al.
        Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.
        Haematologica. 2004; 89: 1187-1193
        • Poggi M.
        • Sorrentino F.
        • Pugliese P.
        • Smacchia M.P.
        • Daniele C.
        • Equitani F.
        • et al.
        Longitudinal changes of endocrine and bone disease in adults with β-thalassemia major receiving different iron chelators over 5 years.
        Ann Hematol. 2016; 95: 757-763
        • Visser J.A.
        • de Jong F.H.
        • Laven J.S.
        • Themmen A.P.
        Anti-Mullerian hormone: a new marker for ovarian function.
        Reproduction. 2006; 131: 1-9
        • Weenen C.
        • Laven J.S.
        • Von Bergh A.R.
        • Cranfield M.
        • Groome N.P.
        • Visser J.A.
        • et al.
        Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.
        Mol Hum Reprod. 2004; 10: 77-83
        • Chang H.M.
        • Klausen C.
        • Leung P.C.
        Antimullerian hormone inhibits follicle-stimulating hormone-induced adenylyl cyclase activation, aromatase expression, and estradiol production in human granulosa-lutein cells.
        Fertil Steril. 2013; 100: 585-592
        • Luisi S.
        • Ciani V.
        • Podfigurna-Stopa A.
        • Lazzeri L.
        • De Pascalis F.
        • Meczekalski B.
        • et al.
        Serum anti-Müllerian hormone, inhibin B, and total inhibin levels in women with hypothalamic amenorrhea and anorexia nervosa.
        Gynecol Endocrinol. 2012; 28: 34-38
        • Sönmezer M.
        • Özmen B.
        • Atabekoglu C.S.
        • Papuccu E.G.
        • Ozkavukcu S.
        • Berker B.
        Serum anti-Mullerian hormone levels correlate with ovarian response in idiopathic hypogonadotropic hypogonadism.
        J Assist Reprod Genet. 2012; 29: 597-602
        • Singer S.T.
        • Vichinsky E.P.
        • Gildengorin G.
        • van Disseldorp J.
        • Rosen M.
        • Cedars M.I.
        Reproductive capacity in iron overloaded women with thalassemia major.
        Blood. 2011; 118: 2878-2881
        • Chang H.H.
        • Chen M.J.
        • Lu M.Y.
        • Chern J.P.
        • Lu C.Y.
        • Yang Y.L.
        • et al.
        Iron overload is associated with low anti-müllerian hormone in women with transfusion-dependent β-thalassaemia.
        BJOG. 2011; 118: 825-831
        • Belhoul K.M.
        • Bakir M.L.
        • Saned M.S.
        • Kadhim A.M.
        • Musallam K.M.
        • Taher A.T.
        Serum ferritin levels and endocrinopathy in medically treated patients with b thalassemia major.
        Ann Hematol. 2012; 91: 1107-1114
        • Noetzli L.J.
        • Panigrahy A.
        • Mittelman S.D.
        • Hyderi A.
        • Dongelyan A.
        • Coates T.D.
        • et al.
        Pituitary iron and volume predict hypogonadism in transfusional iron overload.
        Am J Hematol. 2012; 87: 167-171
        • Oudit G.Y.
        • Sun H.
        • Trivieri M.G.
        • Koch S.E.
        • Dawood F.
        • Ackerley C.
        • et al.
        L-type Ca2z channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy.
        Nat Med. 2003; 9: 1187-1194
        • Ward R.I.
        An update on disordered iron metabolism and iron overload.
        Hematology. 2010; 15: 311-317
        • Wood J.C.
        • Noetzl L.
        • Hyderi A.
        • Joukar M.
        • Coates T.
        • Mittelman S.
        Predicting pituitary iron and endocrine dysfunction.
        Ann N Y Acad Sci. 2010; 1202: 123-128
        • Noetzli L.J.
        • Mittelman S.D.
        • Watanabe R.M.
        • Coates T.D.
        • Wood J.C.
        Pancreatic iron and glucose dysregulation in thalassemia major.
        Am J Hematol. 2012; 87: 155-160
        • Hershko C.
        • Link G.
        • Cabantchik I.
        Pathophysiology of iron overload.
        Ann NY Acad Sci. 1998; 850: 191-201
        • Kitajima M.
        • Defrère S.
        • Dolmans M.M.
        • Colette S.
        • Squifflet J.
        • Van Langendonckt A.
        • et al.
        Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis.
        Fertil Steril. 2011; 96: 685-691
        • Schubert B.
        • Canis M.
        • Darcha C.
        • Artonne C.
        • Pouly J.L.
        • Déchelotte P.
        • et al.
        Human ovarian tissue from cortex surrounding benign cysts: a model to study ovarian tissue cryopreservation.
        Hum Reprod. 2005; 20: 1786-1792
        • Maneschi F.
        • Marasá L.
        • Incandela S.
        • Mazzarese M.
        • Zupi E.
        Ovarian cortex surrounding benign neoplasms: a histologic study.
        Am J Obstet Gynecol. 1993; 169: 388-393
        • Sanchez A.M.
        • Viganò P.
        • Somigliana E.
        • Panina-Bordignon P.
        • Vercellini P.
        • Candiani M.
        The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary.
        Hum Reprod Update. 2014; 20: 217-230
        • Farmaki K.
        • Tzoumari I.
        • Pappa C.
        • Chouliaras G.
        • Berdoukas V.
        Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major.
        Br J Haematol. 2010; 148: 466-475